chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Radiotherapy, Rectal cancer stage IV, Rectal haemorrhage, Respiratory failure, SARS-CoV-2 test negative
Clinical narrative: 1/6/2022- Presents to ED, via ambulance family unable to care for patient, deconditioned  and has fatigue, cough and SOB. Patient had IP stay 12/27-1/5/2022 for acute resp failure s/t CHF exacerbation and CAP, was on 2L NC, IV ceftriaxone and doxy.  Admit Covid + test. Given IV remdesivir, decadron, baricitinib, and doxy. 02 as needed,on 1-2L sat above 98%. Afebrile. 1/9/2022- Rectal bleeding, H&H stable. Sigmoidoscopy performed rectal mass suspicious for malignancy. VSS. Currently on 2L NC 98% sat. 1/10/2022- weaned from 02 use.  1/11/2022-Rectal mass path: adenocarcinoma. D/C decadron change to prednisone. IV doxy to PO doxy. VSS 1/12/2022- Covid hypoxia improving.  1/12/2022- Will f/u with colorectal  specialist post admission for surgical risk d/t antiplatelets and stenting. 1/15/2022- started on Rocephin, d/t possible UTI. 1/16/2022-BP's soft throughout day, 500cc bolus given , VSS. Rectal cancer stage IV.  1/17/2022-Had CT CAP showed liver mets. Will f/u with onc. for chemo after admission. VSS. H&H stable.  1/20/2022- H&H dropped to 7.3 1 unit given.  1/21/2022- Covid antigen negative.  1/23/2022- Hgb 9.5 improved and stable. Continues to maintain Spo2 level on 1-2L nc.  2/1/2022-Palliative Radiation tx, tolerated well. TX mon- friday.  2/6/2022-Hgb 6.8 transfused 1 unit. Pt diaphoretic, dyspenic and substernal pain. Trop indeterminate 0.027. EKG- aberrant conduction along with nonspecific T wave changes. D-Dimer 2,118.  CXR- small pleural effusion noted. 60 mg Lasix given. Steroids and Bipap. Moved to CCU. BP found to be in the &0's Levophed started. Pt is extremely drowsy.  2/7/2022- Levophed now off. On 3L NC now.  2/8/2022-Chest pain resolved. Trop peaked overnight 0.136. TTE ordered. Continue DAPT. Chest CT- no definite pe, large b/l pleural effusions. Bilateral upper lobe dependent atelectasis.  2/9/2022- Stable on 3L NC. Contne intermittent albumin doses with Lasix to mobilize fluid, refused thoracentesis.  2/10/2022- Downgraded to NT3. Stable on 2L NC.  2/17/2022- VSS and Hgb stable, tolerating 2-3 L NC.  2/18/2022- D/C to SNF for deconditioning, Will follow up with oncology and GI. Surgery not an option.
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: SARS-CoV-2 test positive, Sigmoidoscopy abnormal, Somnolence, Transfusion, Troponin increased
Clinical narrative: 1/6/2022- Presents to ED, via ambulance family unable to care for patient, deconditioned  and has fatigue, cough and SOB. Patient had IP stay 12/27-1/5/2022 for acute resp failure s/t CHF exacerbation and CAP, was on 2L NC, IV ceftriaxone and doxy.  Admit Covid + test. Given IV remdesivir, decadron, baricitinib, and doxy. 02 as needed,on 1-2L sat above 98%. Afebrile. 1/9/2022- Rectal bleeding, H&H stable. Sigmoidoscopy performed rectal mass suspicious for malignancy. VSS. Currently on 2L NC 98% sat. 1/10/2022- weaned from 02 use.  1/11/2022-Rectal mass path: adenocarcinoma. D/C decadron change to prednisone. IV doxy to PO doxy. VSS 1/12/2022- Covid hypoxia improving.  1/12/2022- Will f/u with colorectal  specialist post admission for surgical risk d/t antiplatelets and stenting. 1/15/2022- started on Rocephin, d/t possible UTI. 1/16/2022-BP's soft throughout day, 500cc bolus given , VSS. Rectal cancer stage IV.  1/17/2022-Had CT CAP showed liver mets. Will f/u with onc. for chemo after admission. VSS. H&H stable.  1/20/2022- H&H dropped to 7.3 1 unit given.  1/21/2022- Covid antigen negative.  1/23/2022- Hgb 9.5 improved and stable. Continues to maintain Spo2 level on 1-2L nc.  2/1/2022-Palliative Radiation tx, tolerated well. TX mon- friday.  2/6/2022-Hgb 6.8 transfused 1 unit. Pt diaphoretic, dyspenic and substernal pain. Trop indeterminate 0.027. EKG- aberrant conduction along with nonspecific T wave changes. D-Dimer 2,118.  CXR- small pleural effusion noted. 60 mg Lasix given. Steroids and Bipap. Moved to CCU. BP found to be in the &0's Levophed started. Pt is extremely drowsy.  2/7/2022- Levophed now off. On 3L NC now.  2/8/2022-Chest pain resolved. Trop peaked overnight 0.136. TTE ordered. Continue DAPT. Chest CT- no definite pe, large b/l pleural effusions. Bilateral upper lobe dependent atelectasis.  2/9/2022- Stable on 3L NC. Contne intermittent albumin doses with Lasix to mobilize fluid, refused thoracentesis.  2/10/2022- Downgraded to NT3. Stable on 2L NC.  2/17/2022- VSS and Hgb stable, tolerating 2-3 L NC.  2/18/2022- D/C to SNF for deconditioning, Will follow up with oncology and GI. Surgery not an option.
Age: 10.0
Sex: F
Vaccine: UNK
Symptoms: Product preparation issue
Clinical narrative: Patient was due for pfizer age 5-11 booster. The vaccine was not diluted before being administered.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: Patient was given Moderna monovalent for a booster dose, instead of getting moderna bivalent.  No adverse effects.
Age: 58.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Acute respiratory failure, Atelectasis, COVID-19, Chest X-ray abnormal, Chest pain
Clinical narrative: 4/16/2022 PM-Present to ED via EMS from group home, c/o SOB, congestion and chest pain. Hypoxic on RA 87% that improved to 95% on 4L NC weaned to 2L. No oxygen use baseline. R Covid + test.  D-Dimer 714. CXR:patchy linear opacities within both lung bases atelectasis. Admit acute hypoxic respiratory failure Covid. Zosyn and dose given. Start Decadron and azithromycin, .  4/17/2022-Chest CT : moderate size pericardial effusion. Start Doxy , remdesivir and ceftriaxone. Increase need for 02 to 6L NC o2 sat 88-92%.  4/18/2022- O2 sat low to mid 80's on 6L. Bubble bottle applied, o2 increased to 8L no improvement in sat. Placed on NRB at 15 LPM o2 sat increase to 97% Chest PT ordered . On bipap at night 12/6 50% sats mai 4/18/2022- sats maintained at 80-90's.  4/19/2022-D-Dimer 714. Cont. remdesivir and decadron. Start Rocephin and doxy . Having periods on 30L high flow. 4/21/2022- D Dimer 365 4/24/2022- O2 titrated down to 7L nc, VSS.  4/28/2022- Alternating between 10-12L o2 NC. Cont resp distress, non productive cough.Currently on Rocephin, Doxy, Flagyl, Dulera and duoneb, CXR-scateered atelectasis at the bases, right side appears mildly improved.  5/2/2022-Bipap at HS, titrate down from 10 L to 4 L NC. 5/3/2022-wbc 9.9 5/10/2022- Weaned to 2L nc, unable to titrate off. Completed antibiotics. labs improved, D/C home.
Age: 58.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Computerised tomogram thorax abnormal, Cough, Dyspnoea, Fibrin D dimer, Hypoxia
Clinical narrative: 4/16/2022 PM-Present to ED via EMS from group home, c/o SOB, congestion and chest pain. Hypoxic on RA 87% that improved to 95% on 4L NC weaned to 2L. No oxygen use baseline. R Covid + test.  D-Dimer 714. CXR:patchy linear opacities within both lung bases atelectasis. Admit acute hypoxic respiratory failure Covid. Zosyn and dose given. Start Decadron and azithromycin, .  4/17/2022-Chest CT : moderate size pericardial effusion. Start Doxy , remdesivir and ceftriaxone. Increase need for 02 to 6L NC o2 sat 88-92%.  4/18/2022- O2 sat low to mid 80's on 6L. Bubble bottle applied, o2 increased to 8L no improvement in sat. Placed on NRB at 15 LPM o2 sat increase to 97% Chest PT ordered . On bipap at night 12/6 50% sats mai 4/18/2022- sats maintained at 80-90's.  4/19/2022-D-Dimer 714. Cont. remdesivir and decadron. Start Rocephin and doxy . Having periods on 30L high flow. 4/21/2022- D Dimer 365 4/24/2022- O2 titrated down to 7L nc, VSS.  4/28/2022- Alternating between 10-12L o2 NC. Cont resp distress, non productive cough.Currently on Rocephin, Doxy, Flagyl, Dulera and duoneb, CXR-scateered atelectasis at the bases, right side appears mildly improved.  5/2/2022-Bipap at HS, titrate down from 10 L to 4 L NC. 5/3/2022-wbc 9.9 5/10/2022- Weaned to 2L nc, unable to titrate off. Completed antibiotics. labs improved, D/C home.
Age: 58.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Laboratory test abnormal, Lung opacity, Pericardial effusion, Positive airway pressure therapy, Respiratory distress
Clinical narrative: 4/16/2022 PM-Present to ED via EMS from group home, c/o SOB, congestion and chest pain. Hypoxic on RA 87% that improved to 95% on 4L NC weaned to 2L. No oxygen use baseline. R Covid + test.  D-Dimer 714. CXR:patchy linear opacities within both lung bases atelectasis. Admit acute hypoxic respiratory failure Covid. Zosyn and dose given. Start Decadron and azithromycin, .  4/17/2022-Chest CT : moderate size pericardial effusion. Start Doxy , remdesivir and ceftriaxone. Increase need for 02 to 6L NC o2 sat 88-92%.  4/18/2022- O2 sat low to mid 80's on 6L. Bubble bottle applied, o2 increased to 8L no improvement in sat. Placed on NRB at 15 LPM o2 sat increase to 97% Chest PT ordered . On bipap at night 12/6 50% sats mai 4/18/2022- sats maintained at 80-90's.  4/19/2022-D-Dimer 714. Cont. remdesivir and decadron. Start Rocephin and doxy . Having periods on 30L high flow. 4/21/2022- D Dimer 365 4/24/2022- O2 titrated down to 7L nc, VSS.  4/28/2022- Alternating between 10-12L o2 NC. Cont resp distress, non productive cough.Currently on Rocephin, Doxy, Flagyl, Dulera and duoneb, CXR-scateered atelectasis at the bases, right side appears mildly improved.  5/2/2022-Bipap at HS, titrate down from 10 L to 4 L NC. 5/3/2022-wbc 9.9 5/10/2022- Weaned to 2L nc, unable to titrate off. Completed antibiotics. labs improved, D/C home.
Age: 58.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Respiratory tract congestion, SARS-CoV-2 test positive, White blood cell count normal
Clinical narrative: 4/16/2022 PM-Present to ED via EMS from group home, c/o SOB, congestion and chest pain. Hypoxic on RA 87% that improved to 95% on 4L NC weaned to 2L. No oxygen use baseline. R Covid + test.  D-Dimer 714. CXR:patchy linear opacities within both lung bases atelectasis. Admit acute hypoxic respiratory failure Covid. Zosyn and dose given. Start Decadron and azithromycin, .  4/17/2022-Chest CT : moderate size pericardial effusion. Start Doxy , remdesivir and ceftriaxone. Increase need for 02 to 6L NC o2 sat 88-92%.  4/18/2022- O2 sat low to mid 80's on 6L. Bubble bottle applied, o2 increased to 8L no improvement in sat. Placed on NRB at 15 LPM o2 sat increase to 97% Chest PT ordered . On bipap at night 12/6 50% sats mai 4/18/2022- sats maintained at 80-90's.  4/19/2022-D-Dimer 714. Cont. remdesivir and decadron. Start Rocephin and doxy . Having periods on 30L high flow. 4/21/2022- D Dimer 365 4/24/2022- O2 titrated down to 7L nc, VSS.  4/28/2022- Alternating between 10-12L o2 NC. Cont resp distress, non productive cough.Currently on Rocephin, Doxy, Flagyl, Dulera and duoneb, CXR-scateered atelectasis at the bases, right side appears mildly improved.  5/2/2022-Bipap at HS, titrate down from 10 L to 4 L NC. 5/3/2022-wbc 9.9 5/10/2022- Weaned to 2L nc, unable to titrate off. Completed antibiotics. labs improved, D/C home.
Age: 87.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Anticoagulant therapy, Back pain, COVID-19, SARS-CoV-2 test positive, Sciatica
Clinical narrative: 4/24/2022-Presents to Ed c/o back pain and urinary incontinence. X ray : closed compression fracture of L5. zbp-184/79  Norco Given  Admit L5 compression fracture with sciatica, with incontinence (resolving). Covid test -. neuor consult,. UTI , Rocephin ordered.  5/4/2022- Covid + test incidental d/t NH placement, was going to be D/C. Medically stable. Compression fx, conservative treatment PT/OT. HTN stable valsartan, verapamil and metoprolol, BP 110/72. 5/7/2022-Mildly symptomatic this am, VSS. No 02 use needed. Ordered baricitinib and oral steroid. Continue heparin SQ.  5/18/2022- Pt improved, no 02 use. VSS. d/c tohome, made enough progress to not need rehab.
Age: 87.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Spinal X-ray abnormal, Spinal compression fracture, Urinary incontinence, Urinary tract infection
Clinical narrative: 4/24/2022-Presents to Ed c/o back pain and urinary incontinence. X ray : closed compression fracture of L5. zbp-184/79  Norco Given  Admit L5 compression fracture with sciatica, with incontinence (resolving). Covid test -. neuor consult,. UTI , Rocephin ordered.  5/4/2022- Covid + test incidental d/t NH placement, was going to be D/C. Medically stable. Compression fx, conservative treatment PT/OT. HTN stable valsartan, verapamil and metoprolol, BP 110/72. 5/7/2022-Mildly symptomatic this am, VSS. No 02 use needed. Ordered baricitinib and oral steroid. Continue heparin SQ.  5/18/2022- Pt improved, no 02 use. VSS. d/c tohome, made enough progress to not need rehab.
Age: 34.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: Patient had 1st monovalent Pfizer on 08/30/2022.  This nurse gave Pfizer Bivalent dose instead of 2nd monovalent Pfizer dose.  No s/s report as of this date/time.
Age: 59.0
Sex: M
Vaccine: FLU4
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Patient is 59 years old and received a Fluzone Quad High Dose vaccine. According to CDC: Fluzone High-Dose Quadrivalent vaccine is approved only for people 65 years and older. Fluzone High-Dose Quadrivalent is not approved for people younger than 65 years or for people of any age with a history of severe allergic reaction to any influenza vaccine or to vaccine components other than eggs. Information about vaccine ingredients is located in the manufacturer?s package insert.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Bell's palsy, Computerised tomogram, Hypoaesthesia, Laboratory test, Loss of consciousness
Clinical narrative: Woke up Friday Morning and could not feel my face and my teeth hurt. I passed out in my bathroom floor. Rushed to the ER because they thought I had a stroke. I have Bell?s palsy.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Toothache
Clinical narrative: Woke up Friday Morning and could not feel my face and my teeth hurt. I passed out in my bathroom floor. Rushed to the ER because they thought I had a stroke. I have Bell?s palsy.
Age: 39.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Rash, Rash erythematous, Rash papular, Rash pruritic, Rash vesicular
Clinical narrative: Developed left inframammary rash, I'm not sure of the exact date it started.  I first thought it was bug bites, but it is an unlikely location for bug bites, and then another day I saw it had spread.  It was itchy and irritating.  I kept wondering about it.  I developed mild upper respiratory symptoms after a bit less than a week.  I realized my symptoms were very similar to when I had shingles in the past, about 12 years earlier, with the rash starting in the exact same location.  I currently had possible tingles on the back; last time the back part of the rash developed later.  Conducted video visit on 10/10/22.  Doctor observed via video, per notes, "Left inferior to breast - red patches with superimposed papules and vesicles."  Doctor prescribed Valacyclovir for seven days.  I developed a bad cold over the course of treatment.  The rash faded slowly.  Currently, after more than one month, the bump parts are faintly visible, and can be felt as raised bumps, but are not causing irritation.  (Previously had three doses of Moderna Covid vaccine, this was first Pfizer - Pfizer bivalent and flu shot.)
Age: 39.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Respiratory symptom, Skin irritation
Clinical narrative: Developed left inframammary rash, I'm not sure of the exact date it started.  I first thought it was bug bites, but it is an unlikely location for bug bites, and then another day I saw it had spread.  It was itchy and irritating.  I kept wondering about it.  I developed mild upper respiratory symptoms after a bit less than a week.  I realized my symptoms were very similar to when I had shingles in the past, about 12 years earlier, with the rash starting in the exact same location.  I currently had possible tingles on the back; last time the back part of the rash developed later.  Conducted video visit on 10/10/22.  Doctor observed via video, per notes, "Left inferior to breast - red patches with superimposed papules and vesicles."  Doctor prescribed Valacyclovir for seven days.  I developed a bad cold over the course of treatment.  The rash faded slowly.  Currently, after more than one month, the bump parts are faintly visible, and can be felt as raised bumps, but are not causing irritation.  (Previously had three doses of Moderna Covid vaccine, this was first Pfizer - Pfizer bivalent and flu shot.)
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Alanine aminotransferase increased, Ascites, Aspartate aminotransferase increased, Asthenia, Atrial fibrillation
Clinical narrative: 5/4/2022-Presents to ED c/o weakness. Recently d/c from hospital one week ago for sepsis and E coli bacteremia. Afebrile, HR-121. 92% on RA.  CT multilobar pna. Covid + test. CRP-15.2. ALt-39. EKG-a fib RVR. WBC-22.6. Admit sepsis s/t bilateral multilobar pna likely hospital aquired immunocompromised. Zosyn, remdesivir and vanco ordered. Recent IP 4/16-4/26/2022 for EColi in bloodstream.  5/5/2022-HR increase jumpin into the 130's, IV dose Lopressor given. HR remianed in the 120's for most of day Lopressor PO increased to 50-75mg BID.  5/6/2022- ID consult Zosyn d/c, Flagyl and Cefepime started. Vanco continued.
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: C-reactive protein increased, COVID-19, COVID-19 pneumonia, Computerised tomogram abnormal, Computerised tomogram thorax abnormal
Clinical narrative: 5/4/2022-Presents to ED c/o weakness. Recently d/c from hospital one week ago for sepsis and E coli bacteremia. Afebrile, HR-121. 92% on RA.  CT multilobar pna. Covid + test. CRP-15.2. ALt-39. EKG-a fib RVR. WBC-22.6. Admit sepsis s/t bilateral multilobar pna likely hospital aquired immunocompromised. Zosyn, remdesivir and vanco ordered. Recent IP 4/16-4/26/2022 for EColi in bloodstream.  5/5/2022-HR increase jumpin into the 130's, IV dose Lopressor given. HR remianed in the 120's for most of day Lopressor PO increased to 50-75mg BID.  5/6/2022- ID consult Zosyn d/c, Flagyl and Cefepime started. Vanco continued.
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Electrocardiogram abnormal, Escherichia bacteraemia, Facial paralysis, Fibrin D dimer, Heart rate increased
Clinical narrative: 5/4/2022-Presents to ED c/o weakness. Recently d/c from hospital one week ago for sepsis and E coli bacteremia. Afebrile, HR-121. 92% on RA.  CT multilobar pna. Covid + test. CRP-15.2. ALt-39. EKG-a fib RVR. WBC-22.6. Admit sepsis s/t bilateral multilobar pna likely hospital aquired immunocompromised. Zosyn, remdesivir and vanco ordered. Recent IP 4/16-4/26/2022 for EColi in bloodstream.  5/5/2022-HR increase jumpin into the 130's, IV dose Lopressor given. HR remianed in the 120's for most of day Lopressor PO increased to 50-75mg BID.  5/6/2022- ID consult Zosyn d/c, Flagyl and Cefepime started. Vanco continued.
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Hypertransaminasaemia, Immunodeficiency, Infarction, Liver function test decreased, Magnetic resonance imaging normal
Clinical narrative: 5/4/2022-Presents to ED c/o weakness. Recently d/c from hospital one week ago for sepsis and E coli bacteremia. Afebrile, HR-121. 92% on RA.  CT multilobar pna. Covid + test. CRP-15.2. ALt-39. EKG-a fib RVR. WBC-22.6. Admit sepsis s/t bilateral multilobar pna likely hospital aquired immunocompromised. Zosyn, remdesivir and vanco ordered. Recent IP 4/16-4/26/2022 for EColi in bloodstream.  5/5/2022-HR increase jumpin into the 130's, IV dose Lopressor given. HR remianed in the 120's for most of day Lopressor PO increased to 50-75mg BID.  5/6/2022- ID consult Zosyn d/c, Flagyl and Cefepime started. Vanco continued.
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Mental status changes, Metabolic encephalopathy, Pneumonia, SARS-CoV-2 test negative, SARS-CoV-2 test positive
Clinical narrative: 5/4/2022-Presents to ED c/o weakness. Recently d/c from hospital one week ago for sepsis and E coli bacteremia. Afebrile, HR-121. 92% on RA.  CT multilobar pna. Covid + test. CRP-15.2. ALt-39. EKG-a fib RVR. WBC-22.6. Admit sepsis s/t bilateral multilobar pna likely hospital aquired immunocompromised. Zosyn, remdesivir and vanco ordered. Recent IP 4/16-4/26/2022 for EColi in bloodstream.  5/5/2022-HR increase jumpin into the 130's, IV dose Lopressor given. HR remianed in the 120's for most of day Lopressor PO increased to 50-75mg BID.  5/6/2022- ID consult Zosyn d/c, Flagyl and Cefepime started. Vanco continued.
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Sepsis, Serum ferritin increased, Tachypnoea, Ultrasound abdomen abnormal, Urinary tract infection
Clinical narrative: 5/4/2022-Presents to ED c/o weakness. Recently d/c from hospital one week ago for sepsis and E coli bacteremia. Afebrile, HR-121. 92% on RA.  CT multilobar pna. Covid + test. CRP-15.2. ALt-39. EKG-a fib RVR. WBC-22.6. Admit sepsis s/t bilateral multilobar pna likely hospital aquired immunocompromised. Zosyn, remdesivir and vanco ordered. Recent IP 4/16-4/26/2022 for EColi in bloodstream.  5/5/2022-HR increase jumpin into the 130's, IV dose Lopressor given. HR remianed in the 120's for most of day Lopressor PO increased to 50-75mg BID.  5/6/2022- ID consult Zosyn d/c, Flagyl and Cefepime started. Vanco continued.
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: White blood cell count increased
Clinical narrative: 5/4/2022-Presents to ED c/o weakness. Recently d/c from hospital one week ago for sepsis and E coli bacteremia. Afebrile, HR-121. 92% on RA.  CT multilobar pna. Covid + test. CRP-15.2. ALt-39. EKG-a fib RVR. WBC-22.6. Admit sepsis s/t bilateral multilobar pna likely hospital aquired immunocompromised. Zosyn, remdesivir and vanco ordered. Recent IP 4/16-4/26/2022 for EColi in bloodstream.  5/5/2022-HR increase jumpin into the 130's, IV dose Lopressor given. HR remianed in the 120's for most of day Lopressor PO increased to 50-75mg BID.  5/6/2022- ID consult Zosyn d/c, Flagyl and Cefepime started. Vanco continued.
Age: 63.0
Sex: F
Vaccine: HEPAB, HPV9
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: 4th dose of Twinrix was given; HPV given above recommended age group
Age: 58.0
Sex: F
Vaccine: COVID19-2, FLUC4
Symptoms: Fine motor skill dysfunction, Hypoaesthesia, Muscular weakness, Tremor
Clinical narrative: Loss of function of both hands, weakness, numbness. Loss of fine motor control in both hands. Tremors.
Age: 82.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Asthenia, Bladder catheterisation, Blood creatinine increased, COVID-19, Emphysema
Clinical narrative: 5/12/2022- Presents to ED, fatigue and weakness. VSS 96% on RA. Covid + test. UTI. chronic foley cath. Decadron, daptomycin, and ceftriaxone. Was seen in Ed on 5/9 for neg staph enteroccous urine was on Vanco, vanco d/c. Creatnine 1.5 Admit Covid and UTI.  5/13/2022- D Dimer and ferritin normal.  On 2L NC. Creatnine 1.2. Start remdisivir given emphysema.  5/15/2022- Pt left AMA at 1400. Was advised to stay in hospital to finish antibiotics and remdesivir but refused.
Age: 82.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Fatigue, Fibrin D dimer normal, Refusal of treatment by patient, SARS-CoV-2 test positive, Serum ferritin normal
Clinical narrative: 5/12/2022- Presents to ED, fatigue and weakness. VSS 96% on RA. Covid + test. UTI. chronic foley cath. Decadron, daptomycin, and ceftriaxone. Was seen in Ed on 5/9 for neg staph enteroccous urine was on Vanco, vanco d/c. Creatnine 1.5 Admit Covid and UTI.  5/13/2022- D Dimer and ferritin normal.  On 2L NC. Creatnine 1.2. Start remdisivir given emphysema.  5/15/2022- Pt left AMA at 1400. Was advised to stay in hospital to finish antibiotics and remdesivir but refused.
Age: 82.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Staphylococcus test negative, Urinary tract infection
Clinical narrative: 5/12/2022- Presents to ED, fatigue and weakness. VSS 96% on RA. Covid + test. UTI. chronic foley cath. Decadron, daptomycin, and ceftriaxone. Was seen in Ed on 5/9 for neg staph enteroccous urine was on Vanco, vanco d/c. Creatnine 1.5 Admit Covid and UTI.  5/13/2022- D Dimer and ferritin normal.  On 2L NC. Creatnine 1.2. Start remdisivir given emphysema.  5/15/2022- Pt left AMA at 1400. Was advised to stay in hospital to finish antibiotics and remdesivir but refused.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Hospitilization
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Acute kidney injury, Blood creatinine increased, COVID-19, Dehydration, Dyspnoea
Clinical narrative: 5/15/2022- Presents to ED, c/o of SOB and sore throat, tested Covid + at home. Had fever of 100 at home. VSS in ED afebrile. WBC-15.7 , creatnine 1.91 and covid + test. Ordered Decadron , azithromycin and Bebtelovimab. Admit Covid 19.  5/16/2022- AKI s/t to dehydration d/t sore throat. Follow up with Nephro outpatient. Creatnine stable 1.6. WBC-12.6 Complete Zithromax and d/c home.
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Oropharyngeal pain, SARS-CoV-2 test positive, White blood cell count increased
Clinical narrative: 5/15/2022- Presents to ED, c/o of SOB and sore throat, tested Covid + at home. Had fever of 100 at home. VSS in ED afebrile. WBC-15.7 , creatnine 1.91 and covid + test. Ordered Decadron , azithromycin and Bebtelovimab. Admit Covid 19.  5/16/2022- AKI s/t to dehydration d/t sore throat. Follow up with Nephro outpatient. Creatnine stable 1.6. WBC-12.6 Complete Zithromax and d/c home.
Age: 11.0
Sex: F
Vaccine: FLU4
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Patient is 11 years old and received a Fluzone Quad High Dose vaccine. According to CDC: Fluzone High-Dose Quadrivalent vaccine is approved only for people 65 years and older. Fluzone High-Dose Quadrivalent is not approved for people younger than 65 years or for people of any age with a history of severe allergic reaction to any influenza vaccine or to vaccine components other than eggs. Information about vaccine ingredients is located in the manufacturer?s package insert.
Age: 81.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Acute kidney injury, Angiogram, Aortic aneurysm, Blood creatinine normal, Blood sodium increased
Clinical narrative: 5/17/2022-Presents to ED from NH, new onset unresponsiveness. Covid + on 5/7/2022-EGFR-37. WBC-13. Ferritin 626.0. 101.5 temp. Spo2 98% on 3L nc. CT head neg for subacute intracranial abnormality. CT chest-right sided PNA and AAA 6.3 cm with  some wall hemorrhage, CTA bad/pelvis. Sepsis s/t r sided pna with covid infection , concern of aspiration. Ordered baricitinib , vanco, cefepime and Flagyl. Renally adjusted Decadron.   5/19/2022- D/C vanco MRSA swab neg.  NA went up to 152, swithced to D5. Vascular surgery in contact with family regarding endovascular repair likely oupatient. VSS Afebrile.  5/20/2022-BP-166/111 prn hydralazine 10 given, Labetalol 5mg prn ordered, Transferred to cardiovascular ICU gtt @2L. 5/20/-2022- AKIl likely prerenal , resolving. Cont cleviprezx and titrate down, hydralazine 5mg Q6. Continue Flagy, baricitinib and decadron.  5/21/2022- Restart clonidine patch, Toprol daily. Stop hydralazine. VSS BP-115/69. Downgraded to Med/surg.  5/24/2022- Creatnine 1.2. VSS. maintain of RA.  5/25/2022- D/C to sub acute rehab. Nephro follow up. Finished Flagyl, cefepime and baricitnib.
Age: 81.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Body temperature increased, COVID-19, Computerised tomogram head normal, Computerised tomogram thorax abnormal, Glomerular filtration rate decreased
Clinical narrative: 5/17/2022-Presents to ED from NH, new onset unresponsiveness. Covid + on 5/7/2022-EGFR-37. WBC-13. Ferritin 626.0. 101.5 temp. Spo2 98% on 3L nc. CT head neg for subacute intracranial abnormality. CT chest-right sided PNA and AAA 6.3 cm with  some wall hemorrhage, CTA bad/pelvis. Sepsis s/t r sided pna with covid infection , concern of aspiration. Ordered baricitinib , vanco, cefepime and Flagyl. Renally adjusted Decadron.   5/19/2022- D/C vanco MRSA swab neg.  NA went up to 152, swithced to D5. Vascular surgery in contact with family regarding endovascular repair likely oupatient. VSS Afebrile.  5/20/2022-BP-166/111 prn hydralazine 10 given, Labetalol 5mg prn ordered, Transferred to cardiovascular ICU gtt @2L. 5/20/-2022- AKIl likely prerenal , resolving. Cont cleviprezx and titrate down, hydralazine 5mg Q6. Continue Flagy, baricitinib and decadron.  5/21/2022- Restart clonidine patch, Toprol daily. Stop hydralazine. VSS BP-115/69. Downgraded to Med/surg.  5/24/2022- Creatnine 1.2. VSS. maintain of RA.  5/25/2022- D/C to sub acute rehab. Nephro follow up. Finished Flagyl, cefepime and baricitnib.
Age: 81.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Haemorrhage, Intensive care, Pneumonia, SARS-CoV-2 test positive, Sepsis
Clinical narrative: 5/17/2022-Presents to ED from NH, new onset unresponsiveness. Covid + on 5/7/2022-EGFR-37. WBC-13. Ferritin 626.0. 101.5 temp. Spo2 98% on 3L nc. CT head neg for subacute intracranial abnormality. CT chest-right sided PNA and AAA 6.3 cm with  some wall hemorrhage, CTA bad/pelvis. Sepsis s/t r sided pna with covid infection , concern of aspiration. Ordered baricitinib , vanco, cefepime and Flagyl. Renally adjusted Decadron.   5/19/2022- D/C vanco MRSA swab neg.  NA went up to 152, swithced to D5. Vascular surgery in contact with family regarding endovascular repair likely oupatient. VSS Afebrile.  5/20/2022-BP-166/111 prn hydralazine 10 given, Labetalol 5mg prn ordered, Transferred to cardiovascular ICU gtt @2L. 5/20/-2022- AKIl likely prerenal , resolving. Cont cleviprezx and titrate down, hydralazine 5mg Q6. Continue Flagy, baricitinib and decadron.  5/21/2022- Restart clonidine patch, Toprol daily. Stop hydralazine. VSS BP-115/69. Downgraded to Med/surg.  5/24/2022- Creatnine 1.2. VSS. maintain of RA.  5/25/2022- D/C to sub acute rehab. Nephro follow up. Finished Flagyl, cefepime and baricitnib.
Age: 81.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Serum ferritin increased, Staphylococcus test negative, Unresponsive to stimuli, White blood cell count increased
Clinical narrative: 5/17/2022-Presents to ED from NH, new onset unresponsiveness. Covid + on 5/7/2022-EGFR-37. WBC-13. Ferritin 626.0. 101.5 temp. Spo2 98% on 3L nc. CT head neg for subacute intracranial abnormality. CT chest-right sided PNA and AAA 6.3 cm with  some wall hemorrhage, CTA bad/pelvis. Sepsis s/t r sided pna with covid infection , concern of aspiration. Ordered baricitinib , vanco, cefepime and Flagyl. Renally adjusted Decadron.   5/19/2022- D/C vanco MRSA swab neg.  NA went up to 152, swithced to D5. Vascular surgery in contact with family regarding endovascular repair likely oupatient. VSS Afebrile.  5/20/2022-BP-166/111 prn hydralazine 10 given, Labetalol 5mg prn ordered, Transferred to cardiovascular ICU gtt @2L. 5/20/-2022- AKIl likely prerenal , resolving. Cont cleviprezx and titrate down, hydralazine 5mg Q6. Continue Flagy, baricitinib and decadron.  5/21/2022- Restart clonidine patch, Toprol daily. Stop hydralazine. VSS BP-115/69. Downgraded to Med/surg.  5/24/2022- Creatnine 1.2. VSS. maintain of RA.  5/25/2022- D/C to sub acute rehab. Nephro follow up. Finished Flagyl, cefepime and baricitnib.
Age: 46.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: There weren't any adverse reactions from this shot. However, the patient was supposed to get a second primary dose for her COVID-19 shot and we, unfortunately, marked it down as a COVID booster shot.
Age: 80.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Asthenia, COVID-19, Chest X-ray abnormal, Computerised tomogram head abnormal, Confusional state
Clinical narrative: 5/30/2022- Presents to Ed, weakness, confusion, slurred speech. Ct head- on acute intracranial hemorrhage. Covid + test. Incidental finding. CXR- mp focal infiltrates. Ordered Bebtelovimab.  Not a candidate for tPA due to low NIH score and thrombectomy d/t lack of arterial target. Ordered ASA, plavix. Pt refused anticoagulation s/t past GI bleding with Xarelto.  6/1/2022- Maintaining 02 sat.  VSS 6/2/022- MRI brain negative. Stable on RA. D/C to home with stroke team and cardio f/u.
Age: 80.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Dysarthria, Haemorrhage intracranial, Lung infiltration, Magnetic resonance imaging head normal, NIH stroke scale score decreased
Clinical narrative: 5/30/2022- Presents to Ed, weakness, confusion, slurred speech. Ct head- on acute intracranial hemorrhage. Covid + test. Incidental finding. CXR- mp focal infiltrates. Ordered Bebtelovimab.  Not a candidate for tPA due to low NIH score and thrombectomy d/t lack of arterial target. Ordered ASA, plavix. Pt refused anticoagulation s/t past GI bleding with Xarelto.  6/1/2022- Maintaining 02 sat.  VSS 6/2/022- MRI brain negative. Stable on RA. D/C to home with stroke team and cardio f/u.
Age: 80.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: SARS-CoV-2 test positive, Thrombectomy
Clinical narrative: 5/30/2022- Presents to Ed, weakness, confusion, slurred speech. Ct head- on acute intracranial hemorrhage. Covid + test. Incidental finding. CXR- mp focal infiltrates. Ordered Bebtelovimab.  Not a candidate for tPA due to low NIH score and thrombectomy d/t lack of arterial target. Ordered ASA, plavix. Pt refused anticoagulation s/t past GI bleding with Xarelto.  6/1/2022- Maintaining 02 sat.  VSS 6/2/022- MRI brain negative. Stable on RA. D/C to home with stroke team and cardio f/u.
Age: 36.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: COVID booster was given, patient needed a primary COVID vaccine
Age: 83.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Acidosis, Anion gap, Atelectasis, Blood bicarbonate decreased, Blood creatinine increased
Clinical narrative: 5/21/2022-Presents Ed via EMS, at home intially sinus brady hypotensive transcutaneously paced. Hr-40, systolic around 70 mmHg on norepinephrine mcg/min.  Intubated.  Had IO of R shoulder due to inability to place IV access. Admit hemodynamically significant bradycarida in the setting of severe mtabolic derangeent and metabolic acidosis. Potassium 7 and creatnine above 6 . CXR: bibasilar linear atelectasis.  Covid + test. Hemodialsysi catheter via IJ for emergenct dislaysis. Pancreatits based on abd CTand  lipase over 4000. Transfered to ICU.   Temporary venous pacemaker placed along with hemodialysis catheter. Vent settings Fio2 100% resp 16 ABG: 6.9/27.2 bicarb less then 6 and anion gap more then 19 Ordered IV meropenem and pressor support.  5/22/2022-Bicarb drip started , acidosis improving. Monoclonals and steroids not recommended due to amount of renal failure. Vent settings Fio2 50% resp 10 Family discussion, Patient made palliative. Terminal exubation. Time of death 1600.
Age: 83.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood gases, Blood potassium increased, Bradycardia, COVID-19, Catheter placement
Clinical narrative: 5/21/2022-Presents Ed via EMS, at home intially sinus brady hypotensive transcutaneously paced. Hr-40, systolic around 70 mmHg on norepinephrine mcg/min.  Intubated.  Had IO of R shoulder due to inability to place IV access. Admit hemodynamically significant bradycarida in the setting of severe mtabolic derangeent and metabolic acidosis. Potassium 7 and creatnine above 6 . CXR: bibasilar linear atelectasis.  Covid + test. Hemodialsysi catheter via IJ for emergenct dislaysis. Pancreatits based on abd CTand  lipase over 4000. Transfered to ICU.   Temporary venous pacemaker placed along with hemodialysis catheter. Vent settings Fio2 100% resp 16 ABG: 6.9/27.2 bicarb less then 6 and anion gap more then 19 Ordered IV meropenem and pressor support.  5/22/2022-Bicarb drip started , acidosis improving. Monoclonals and steroids not recommended due to amount of renal failure. Vent settings Fio2 50% resp 10 Family discussion, Patient made palliative. Terminal exubation. Time of death 1600.
Age: 83.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Chest X-ray abnormal, Computerised tomogram abdomen abnormal, Death, Dialysis, Endotracheal intubation
Clinical narrative: 5/21/2022-Presents Ed via EMS, at home intially sinus brady hypotensive transcutaneously paced. Hr-40, systolic around 70 mmHg on norepinephrine mcg/min.  Intubated.  Had IO of R shoulder due to inability to place IV access. Admit hemodynamically significant bradycarida in the setting of severe mtabolic derangeent and metabolic acidosis. Potassium 7 and creatnine above 6 . CXR: bibasilar linear atelectasis.  Covid + test. Hemodialsysi catheter via IJ for emergenct dislaysis. Pancreatits based on abd CTand  lipase over 4000. Transfered to ICU.   Temporary venous pacemaker placed along with hemodialysis catheter. Vent settings Fio2 100% resp 16 ABG: 6.9/27.2 bicarb less then 6 and anion gap more then 19 Ordered IV meropenem and pressor support.  5/22/2022-Bicarb drip started , acidosis improving. Monoclonals and steroids not recommended due to amount of renal failure. Vent settings Fio2 50% resp 10 Family discussion, Patient made palliative. Terminal exubation. Time of death 1600.
Age: 83.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Hypotension, Intensive care, Intraosseous access placement, Lipase increased, Metabolic acidosis
Clinical narrative: 5/21/2022-Presents Ed via EMS, at home intially sinus brady hypotensive transcutaneously paced. Hr-40, systolic around 70 mmHg on norepinephrine mcg/min.  Intubated.  Had IO of R shoulder due to inability to place IV access. Admit hemodynamically significant bradycarida in the setting of severe mtabolic derangeent and metabolic acidosis. Potassium 7 and creatnine above 6 . CXR: bibasilar linear atelectasis.  Covid + test. Hemodialsysi catheter via IJ for emergenct dislaysis. Pancreatits based on abd CTand  lipase over 4000. Transfered to ICU.   Temporary venous pacemaker placed along with hemodialysis catheter. Vent settings Fio2 100% resp 16 ABG: 6.9/27.2 bicarb less then 6 and anion gap more then 19 Ordered IV meropenem and pressor support.  5/22/2022-Bicarb drip started , acidosis improving. Monoclonals and steroids not recommended due to amount of renal failure. Vent settings Fio2 50% resp 10 Family discussion, Patient made palliative. Terminal exubation. Time of death 1600.
Age: 83.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Metabolic syndrome, Pancreatitis, Renal failure, SARS-CoV-2 test positive, Sinus bradycardia
Clinical narrative: 5/21/2022-Presents Ed via EMS, at home intially sinus brady hypotensive transcutaneously paced. Hr-40, systolic around 70 mmHg on norepinephrine mcg/min.  Intubated.  Had IO of R shoulder due to inability to place IV access. Admit hemodynamically significant bradycarida in the setting of severe mtabolic derangeent and metabolic acidosis. Potassium 7 and creatnine above 6 . CXR: bibasilar linear atelectasis.  Covid + test. Hemodialsysi catheter via IJ for emergenct dislaysis. Pancreatits based on abd CTand  lipase over 4000. Transfered to ICU.   Temporary venous pacemaker placed along with hemodialysis catheter. Vent settings Fio2 100% resp 16 ABG: 6.9/27.2 bicarb less then 6 and anion gap more then 19 Ordered IV meropenem and pressor support.  5/22/2022-Bicarb drip started , acidosis improving. Monoclonals and steroids not recommended due to amount of renal failure. Vent settings Fio2 50% resp 10 Family discussion, Patient made palliative. Terminal exubation. Time of death 1600.
Age: 83.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Temporary transvenous pacing
Clinical narrative: 5/21/2022-Presents Ed via EMS, at home intially sinus brady hypotensive transcutaneously paced. Hr-40, systolic around 70 mmHg on norepinephrine mcg/min.  Intubated.  Had IO of R shoulder due to inability to place IV access. Admit hemodynamically significant bradycarida in the setting of severe mtabolic derangeent and metabolic acidosis. Potassium 7 and creatnine above 6 . CXR: bibasilar linear atelectasis.  Covid + test. Hemodialsysi catheter via IJ for emergenct dislaysis. Pancreatits based on abd CTand  lipase over 4000. Transfered to ICU.   Temporary venous pacemaker placed along with hemodialysis catheter. Vent settings Fio2 100% resp 16 ABG: 6.9/27.2 bicarb less then 6 and anion gap more then 19 Ordered IV meropenem and pressor support.  5/22/2022-Bicarb drip started , acidosis improving. Monoclonals and steroids not recommended due to amount of renal failure. Vent settings Fio2 50% resp 10 Family discussion, Patient made palliative. Terminal exubation. Time of death 1600.
Age: 2.0
Sex: F
Vaccine: FLU4
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Patient is 2 years old and received a Fluzone Quad High Dose vaccine. According to CDC: Fluzone High-Dose Quadrivalent vaccine is approved only for people 65 years and older. Fluzone High-Dose Quadrivalent is not approved for people younger than 65 years or for people of any age with a history of severe allergic reaction to any influenza vaccine or to vaccine components other than eggs. Information about vaccine ingredients is located in the manufacturer?s package insert.
Age: 56.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Anticoagulant therapy, Aortic aneurysm repair, COVID-19, COVID-19 pneumonia, Cardiomegaly
Clinical narrative: 5/30/2022-Presents to ED, c/o of abrupt chest pain. AAA repair done on 5/3/2022. Covid + test. Afebrile BP 86/62. Resp 24. Admit septic shock  and b/l Covid PNA. Not hypoxic on 2 mic of Levophed. Maintaining 02 on RA. UA revealed WBC above 180. CXR: multilobar r lung infiltrate. Cardiomegaly with signs of pulmonary edema: Ordered Lasix, prednisone, bebtelovima, cefepime and Doxy. Urology consulted continue with IV antibiotics.  5/31/2022- On heparin gtt, off Levophed. Continue cefepime and doxy.  6/1/2022- Transfer out of ICU. Continue IV lasix,  Follow up with Urology for stent outpatient. Off pressors. VSS stable on RA. D/C home.
Age: 56.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Chest X-ray abnormal, Chest pain, Intensive care, Lung infiltration, Pulmonary oedema
Clinical narrative: 5/30/2022-Presents to ED, c/o of abrupt chest pain. AAA repair done on 5/3/2022. Covid + test. Afebrile BP 86/62. Resp 24. Admit septic shock  and b/l Covid PNA. Not hypoxic on 2 mic of Levophed. Maintaining 02 on RA. UA revealed WBC above 180. CXR: multilobar r lung infiltrate. Cardiomegaly with signs of pulmonary edema: Ordered Lasix, prednisone, bebtelovima, cefepime and Doxy. Urology consulted continue with IV antibiotics.  5/31/2022- On heparin gtt, off Levophed. Continue cefepime and doxy.  6/1/2022- Transfer out of ICU. Continue IV lasix,  Follow up with Urology for stent outpatient. Off pressors. VSS stable on RA. D/C home.
Age: 56.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: SARS-CoV-2 test positive, Septic shock, Urine analysis abnormal, White blood cells urine positive
Clinical narrative: 5/30/2022-Presents to ED, c/o of abrupt chest pain. AAA repair done on 5/3/2022. Covid + test. Afebrile BP 86/62. Resp 24. Admit septic shock  and b/l Covid PNA. Not hypoxic on 2 mic of Levophed. Maintaining 02 on RA. UA revealed WBC above 180. CXR: multilobar r lung infiltrate. Cardiomegaly with signs of pulmonary edema: Ordered Lasix, prednisone, bebtelovima, cefepime and Doxy. Urology consulted continue with IV antibiotics.  5/31/2022- On heparin gtt, off Levophed. Continue cefepime and doxy.  6/1/2022- Transfer out of ICU. Continue IV lasix,  Follow up with Urology for stent outpatient. Off pressors. VSS stable on RA. D/C home.
Age: 91.0
Sex: F
Vaccine: COVID19-2
Symptoms: Anticoagulant therapy, Atrial fibrillation, Cardioversion
Clinical narrative: New acute onset of atrial fibrillation. Hospitalized with cardioversion performed. Now on Eliquis and Metoprolol.
Age: 90.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Animal bite, C-reactive protein, COVID-19, Cardiac failure congestive, Chest X-ray abnormal
Clinical narrative: 6/1/32022-Presents to ED, SOB, fatigue, decreased appetite, nausea and diarrhea. Pt on Augmentn for cat bite wound. Afebrile, On 2L NC  94% spo2.. Covid + test. CRP. Ordered Decadron, ceftriaxone and doxy. CXR-pulmonary edema.  Admit CHF exacerbation Covid . 6/14/2022- Started on remdesivir and barictininb.  6/16/2022- Weaned down to RA, spo2 95%. 6/21/2022-Completed remdesivir , d/c steroids and baricitinib as no further resp symptoms at day 5. VSS afebrile.  6/24/2022- D/C to SNF .
Age: 90.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Condition aggravated, Decreased appetite, Diarrhoea, Dyspnoea, Fatigue
Clinical narrative: 6/1/32022-Presents to ED, SOB, fatigue, decreased appetite, nausea and diarrhea. Pt on Augmentn for cat bite wound. Afebrile, On 2L NC  94% spo2.. Covid + test. CRP. Ordered Decadron, ceftriaxone and doxy. CXR-pulmonary edema.  Admit CHF exacerbation Covid . 6/14/2022- Started on remdesivir and barictininb.  6/16/2022- Weaned down to RA, spo2 95%. 6/21/2022-Completed remdesivir , d/c steroids and baricitinib as no further resp symptoms at day 5. VSS afebrile.  6/24/2022- D/C to SNF .
Age: 90.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Nausea, Pulmonary oedema, SARS-CoV-2 test positive
Clinical narrative: 6/1/32022-Presents to ED, SOB, fatigue, decreased appetite, nausea and diarrhea. Pt on Augmentn for cat bite wound. Afebrile, On 2L NC  94% spo2.. Covid + test. CRP. Ordered Decadron, ceftriaxone and doxy. CXR-pulmonary edema.  Admit CHF exacerbation Covid . 6/14/2022- Started on remdesivir and barictininb.  6/16/2022- Weaned down to RA, spo2 95%. 6/21/2022-Completed remdesivir , d/c steroids and baricitinib as no further resp symptoms at day 5. VSS afebrile.  6/24/2022- D/C to SNF .
Age: 73.0
Sex: M
Vaccine: COVID19-2, FLU4
Symptoms: Laboratory test, Peripheral swelling, Swelling, Ultrasound scan
Clinical narrative: LEFT ARM AND SPREAD TO CHEST SWOLLOW TWICE THE NORMAL SIZE
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Acute respiratory failure, Blood gases, COVID-19, COVID-19 pneumonia, Computerised tomogram head abnormal
Clinical narrative: 6/24/2022-Presents to ED, + home covid test and coughing. Covid + test. ABG-7.46/34.1/32/24.4. CT chest bibasilar mild consolidation and minimal plueral effusions. 2L NC 96%.HR-113.  Ordered dexamthasone, CAP coverage IV azithromycin , Rocephin and Remdesivir. Intial bp was 76/45 bolus given, now 89/50, patients baseline. MAP is around 63-65, started on levophed and fluids were d/c questionable HF. WBC 3.1 was 6.1 6 days prior, leukopenia immunotherapy in the setting of multiple myeloma. D Dimer 1125, CT was negative for PE. Admit acute hypoxic rep distress s/t to Covid pna.  6/26/2022- D/C remdesivir, no longer hypoxic. VSS. WBC 4.3. 6/28/2022-Continues on RA for 02, completed IV azithromycin and Rocephin course. VSS. D/CLevophed map around 70's. D/C Home.
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Computerised tomogram thorax abnormal, Cough, Fibrin D dimer increased, Leukopenia, Lung consolidation
Clinical narrative: 6/24/2022-Presents to ED, + home covid test and coughing. Covid + test. ABG-7.46/34.1/32/24.4. CT chest bibasilar mild consolidation and minimal plueral effusions. 2L NC 96%.HR-113.  Ordered dexamthasone, CAP coverage IV azithromycin , Rocephin and Remdesivir. Intial bp was 76/45 bolus given, now 89/50, patients baseline. MAP is around 63-65, started on levophed and fluids were d/c questionable HF. WBC 3.1 was 6.1 6 days prior, leukopenia immunotherapy in the setting of multiple myeloma. D Dimer 1125, CT was negative for PE. Admit acute hypoxic rep distress s/t to Covid pna.  6/26/2022- D/C remdesivir, no longer hypoxic. VSS. WBC 4.3. 6/28/2022-Continues on RA for 02, completed IV azithromycin and Rocephin course. VSS. D/CLevophed map around 70's. D/C Home.